Private Advisor Group’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.06M Buy
10,451
+625
+6% +$205K 0.01% 846
2025
Q4
$3.44M Sell
9,826
-121
-1% -$40.9K 0.02% 789
2025
Q3
$3.21M Sell
9,947
-557
-5% -$173K 0.02% 803
2025
Q2
$4.09M Buy
10,504
+534
+5% +$215K 0.02% 652
2025
Q1
$4.34M Buy
9,970
+468
+5% +$188K 0.03% 588
2024
Q4
$3.51M Sell
9,502
-2,311
-20% -$967K 0.02% 649
2024
Q3
$6.14M Sell
11,813
-1,290
-10% -$689K 0.04% 451
2024
Q2
$7.1M Buy
13,103
+876
+7% +$463K 0.05% 363
2024
Q1
$6.34M Sell
12,227
-250
-2% -$124K 0.05% 387
2023
Q4
$5.88M Sell
12,477
-272
-2% -$126K 0.05% 374
2023
Q3
$5.55M Buy
12,749
+1,592
+14% +$722K 0.05% 363
2023
Q2
$5.03M Buy
11,157
+1,475
+15% +$680K 0.04% 397
2023
Q1
$4.45M Sell
9,682
-1,077
-10% -$513K 0.04% 417
2022
Q4
$1.08M Buy
10,759
+1,008
+10% +$512K 0.05% 341
2022
Q3
$4.43M Sell
9,751
-3,333
-25% -$1.59M 0.05% 367
2022
Q2
$6.31M Buy
13,084
+204
+2% +$101K 0.06% 334
2022
Q1
$6.33M Buy
12,880
+1,581
+14% +$723K 0.05% 361
2021
Q4
$5.24M Sell
11,299
-1,939
-15% -$816K 0.04% 439
2021
Q3
$4.94M Buy
13,238
+4,346
+49% +$1.65M 0.03% 516
2021
Q2
$3.4M Sell
8,892
-10,338
-54% -$3.95M 0.03% 548
2021
Q1
$6.9M Buy
19,230
+10,192
+113% +$3.28M 0.07% 292
2020
Q4
$2.9M Buy
9,038
+825
+10% +$253K 0.03% 530
2020
Q3
$2.19M Buy
8,213
+552
+7% +$149K 0.03% 523
2020
Q2
$2.02M Buy
7,661
+352
+5% +$93.9K 0.03% 536
2020
Q1
$1.66M Sell
7,309
-1,493
-17% -$407K 0.03% 494
2019
Q4
$2.66M Sell
8,802
-1,008
-10% -$277K 0.04% 444
2019
Q3
$2.42M Buy
9,810
+2,546
+35% +$698K 0.04% 483
2019
Q2
$2.05M Buy
7,264
+3,570
+97% +$975K 0.04% 476
2019
Q1
$1.06M Buy
3,694
+328
+10% +$94.9K 0.02% 636
2018
Q4
$885K Buy
3,366
+982
+41% +$270K 0.02% 623
2018
Q3
$653K Sell
2,384
-9,003
-79% -$2.34M 0.01% 876
2018
Q2
$2.71M Buy
11,387
+9,493
+501% +$2.2M 0.04% 207
2018
Q1
$417K Sell
1,894
-932
-33% -$219K 0.02% 741
2017
Q4
$652K Sell
2,826
-1,214
-30% -$259K 0.03% 541
2017
Q3
$770K Sell
4,040
-839
-17% -$160K 0.02% 677
2017
Q2
$937K Sell
4,879
-406
-8% -$72.9K 0.03% 563
2017
Q1
$524K Buy
5,285
+2,687
+103% +$427K 0.01% 805
2016
Q4
$378K Buy
2,598
+683
+36% +$91.5K 0.01% 851
2016
Q3
$235K Sell
1,915
-605
-24% -$78.1K 0.01% 941
2016
Q2
$333K Sell
2,520
-2,660
-51% -$364K 0.01% 773
2016
Q1
$682K Buy
+5,180
New +$692K 0.03% 469

Other funds holding ELV

Private Advisor Group's ELV Position: Q1 2026 in Review

Private Advisor Group increased its Elevance Health (ELV) stake by 6.4% in Q1 2026, buying an estimated $205K and bringing the position to 10,451 shares worth $3.06M. The position accounts for 0.01% of the portfolio, ranked #846.

Private Advisor Group first reported a position in ELV in Q1 2016 and has held it in 41 quarters since. The position peaked at $7.1M in Q2 2024. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Private Advisor Group held 10,451 shares of Elevance Health worth $3.06M as of Q1 2026.
  • Private Advisor Group bought 625 Elevance Health shares in Q1 2026, an estimated $205K.
  • Elevance Health made up 0.01% of Private Advisor Group's portfolio in Q1 2026, its #846 holding.
  • Private Advisor Group first reported a position in Elevance Health in Q1 2016 and has held it in 41 quarters since.
  • Private Advisor Group's Elevance Health position peaked at $7.1M in Q2 2024.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Private Advisor Group's 13F filing for Q1 2026, filed 27 Apr 2026.